-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Two Enterprises of Shijiazhuang Sihua Pharmaceutical Group Selected for Inclusion in the 2025 Provincial Doctoral Innovation Station Construction Project Recognition List
Category:
TIME：2025-10-10
Recently, the Hebei Provincial Association for Science and Technology, the Hebei Provincial Department of Education, and the Hebei Provincial Federation of Industry and Commerce publicly announced the first batch of 300 Hebei Provincial Doctoral Innovation Station construction projects for 2025, which were jointly selected and approved. Shijiazhuang Sihua Pharmaceutical Group’s Shijiazhuang Sihua Pharmaceutical Co., Ltd. and Hebei Guangxiang Pharmaceutical Co., Ltd. were both included on the list, demonstrating the Group’s remarkable achievements in building capabilities in scientific research innovation, industry–university–research collaboration, and high-level talent services.
According to reports, the Hebei Provincial Doctoral Innovation Station Construction Project is jointly promoted by the Hebei Provincial Association for Science and Technology, the Hebei Provincial Department of Education, and the Hebei Provincial Federation of Industry and Commerce. It represents a key initiative for thoroughly implementing the spirit of the 20th National Congress of the Communist Party of China and the Second and Third Plenary Sessions of the 20th CPC Central Committee, for deepening the implementation of the innovation-driven development strategy, for fostering the deep integration of technological innovation and industrial innovation, and for supporting high-quality economic development in Hebei Province. The project is centered on the development needs of Hebei’s eight key industries and 107 county-level specialized industrial clusters, and, guided by the “Five Ones” standard, it encourages university doctoral teams to co-establish innovation stations with enterprises. By doing so, it seeks to address the dual challenges faced by enterprises—namely, difficulties in accessing advanced technologies and a shortage of skilled talent—and by doctoral researchers—namely, a lack of viable projects and limited practical experience—thereby establishing a new mechanism for the deep integration of industry, academia, research, and application and injecting technological momentum into the region’s high-quality economic development. The designation of provincial doctoral innovation stations is determined through a series of procedures—including voluntary applications, selection and recommendation, formal review, and expert evaluation—in accordance with the requirements set forth in the “Notice on Implementing the 2025 Hebei Provincial Doctoral Innovation Station Construction Project,” jointly issued by the Hebei Provincial Association for Science and Technology, the Hebei Provincial Department of Education, and the Hebei Provincial Federation of Industry and Commerce.
As a pillar enterprise in the province’s biopharmaceutical industry, Shijiazhuang Sihua Pharmaceutical Group has, in recent years, remained firmly aligned with national strategies and market demands. The company has positioned the R&D of innovative drugs, high-end complex formulations, and specialty active pharmaceutical ingredients as its strategic fulcrums, systematically advancing basic research, technological breakthroughs, and industrial application. By establishing innovation ecosystems that integrate industry, academia, research, and end-use applications, as well as fostering deep integration between industry and education and robust university–enterprise collaboration, the Group has joined forces with renowned institutions and research organizations—including China Pharmaceutical University, Shenyang Pharmaceutical University, Lanzhou University, and Hebei Medical University—to achieve synergistic development through the integrated allocation of industrial-chain resources, enhanced efficiency of the innovation chain, and optimized talent management. These efforts have yielded remarkable results in tackling critical core technologies and translating research outcomes into practical applications. Today, the Group has established an innovation ecosystem driven by both API production and formulation development, continuously strengthening its core competitiveness and injecting new momentum into its high-quality, innovation-led growth.
A relevant official from the group stated, “Going forward, we will continue to leverage the establishment of the Doctoral Innovation Stations, closely align with the company’s research priorities, further deepen collaboration with universities and research institutes, tackle key technological bottlenecks, accelerate technological upgrades and the optimization and transformation of our product portfolio, develop and manufacture more ‘Made-in-China’ pharmaceuticals, and strive to make greater contributions to the high-quality development of our province’s biopharmaceutical industry and to the building of a Healthy China.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
